Metformin boosts an exercise-linked metabolite and may help control weight in prostate cancer patients
Metformin raised the exercise-linked metabolite Lac-Phe in prostate cancer patients across disease stages and treatment settings, while Lac-Phe itself did not predict anticancer response. Patients in the BIMET-1 metformin arm…